Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

CAPS Rating: 2 out of 5

Results 1 - 5 of 5

Recs

0
Member Avatar Irene8777 (< 20) Submitted: 7/6/2013 5:43:32 AM : Outperform Start Price: $71.49 AEGR Score: -82.24

STOCK WENT UP BY 350 PERCENT IN TWO YEARS.

Recs

1
Member Avatar TheStockDoctor (< 20) Submitted: 3/3/2013 9:01:48 PM : Outperform Start Price: $31.40 AEGR Score: -42.45

With AEGR focused on an orphan drug with no alternative treatments available and only a single potential competitor that has significant side effects, AEGR becomes a compelling buy.

Recs

0
Member Avatar CarlosDK (< 20) Submitted: 1/16/2013 2:05:22 PM : Underperform Start Price: $27.26 AEGR Score: +33.20

stockcon short

Recs

0
Member Avatar IBDContrarian (36.67) Submitted: 12/18/2012 10:42:41 AM : Underperform Start Price: $23.00 AEGR Score: +16.69

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MEDICAL 6 97 --B+, NO EARNINGS

Recs

1
Member Avatar EvilEmpire (29.11) Submitted: 7/25/2012 7:04:34 PM : Outperform Start Price: $14.12 AEGR Score: +50.18

PDUFA + BB

Results 1 - 5 of 5

Featured Broker Partners


Advertisement